Page last updated: 2024-08-23

etoposide and 2019 Novel Coronavirus Disease

etoposide has been researched along with 2019 Novel Coronavirus Disease in 23 studies

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	23 (100.00)	2.80

Authors

Authors	Studies
Lin, J; Routy, JP; Samoukovic, G; Wiseman, D	1
Arredondo, A; Babiker, H; Banh, C; Boiles, AR; Elquza, E; Kraft, A; McBride, A; Notbohm, K; Ortega, A; Persky, D; Valsvik, K	1
Eichenauer, DA; Hallek, M; Hieber, ML; Jachimowicz, RD; Sprute, R	1
Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L	1
Hayashi, T; Hiki, M; Masuda, K; Miura, K; Nagata, Y; Seto, K; Shukuya, T; Suzuki, K; Tajima, K; Takahashi, K; Takahashi, R; Tanabe, Y; Watanabe, T	1
Baltogianni, M; Bouza, H; Farmaki, E; Giapros, V; Kosmeri, C; Lianou, L; Lykopoulou, L; Makis, A; Papadakis, V; Papadopoulou, E; Rallis, D; Tzanoudaki, M	1
Barathi, D; Dahagama, S; Dubashi, B; Ganesan, P; Goenka, L; Kayal, S; Krishnamoorthy, N; Mathaiyan, J; Nakka, T; Thumaty, DB	1
Anderson, MK; Halford, Z; Summerlin, J; Wells, DA	1
Bosi, GR; Soldera, J	1
Koller, A; Szebeni, J	1
Angelov, D; Cotter, AG; Fay, M; Lambert, JS; McGettrick, P; McGinty, T; O'Kelly, B; Sheehan, G	1
Takami, A	2
Aouidane, S; Belaaloui, G; Hamizi, K	1
Loscocco, GG	1
E, I; F, C; G, H; I, A; J, M; L, B; M, FR; M, LV; M, MB; M, U; P, D	1
Fan, L; Li, JY; Miao, Y	1
Bromberg, M; Caricchio, R; Chandar, A; Criner, GJ; Desai, P; Dominguez, E; Patel, M; Sacher, D	1
Lovetrue, B	1
Bajorin, DF; Bosl, GJ; Bromberg, M; Carousso, M; Carver, BS; Feldman, DR; Funt, SA; Knezevic, A; McHugh, DJ; Motzer, RJ; O'Donnell, D; Patil, S; Reuter, VE; Sheinfeld, J; Silber, D; Tsai, S	1
Kapoor, R; Rastogi, N; Sarma, S; Thakkar, D; Wadhwa, T; Yadav, SP	1
Al-Otaibi, A; Alabbas, F; Alhumaidan, W; Ali, TB; Elyamany, G	1
Astigarraga, I; Buzón-Martín, L; Delgado-López, PD; Montero-Baladia, M	1

Reviews

2 review(s) available for etoposide and 2019 Novel Coronavirus Disease

Article	Year
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID-19 infection. Thoracic cancer, 2022, Volume: 13, Issue:18 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; COVID-19; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; RNA, Viral; SARS-CoV-2; Testicular Neoplasms	2022
A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis. The Annals of pharmacotherapy, 2023, Volume: 57, Issue:7 Topics: Adult; Child; COVID-19; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic	2023

Trials

1 trial(s) available for etoposide and 2019 Novel Coronavirus Disease

Article	Year
Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer. Medical oncology (Northwood, London, England), 2022, Sep-29, Volume: 39, Issue:12 Topics: Carcinoma, Ovarian Epithelial; Communicable Disease Control; COVID-19; Cytotoxins; Etoposide; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lymphoma, Follicular; Middle Aged; Ovarian Neoplasms; Prospective Studies; Sodium; Valproic Acid	2022

Article

Year

Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer.

Medical oncology (Northwood, London, England), 2022, Sep-29, Volume: 39, Issue:12

Topics: Carcinoma, Ovarian Epithelial; Communicable Disease Control; COVID-19; Cytotoxins; Etoposide; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lymphoma, Follicular; Middle Aged; Ovarian Neoplasms; Prospective Studies; Sodium; Valproic Acid

2022

Other Studies

20 other study(ies) available for etoposide and 2019 Novel Coronavirus Disease

Article	Year
Haemophagocytic lymphohistiocytosis in an adult with postacute COVID-19 syndrome. BMJ case reports, 2021, Sep-13, Volume: 14, Issue:9 Topics: Adult; COVID-19; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; SARS-CoV-2	2021
Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022, Volume: 30, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cost Savings; COVID-19; Etoposide; Humans; Ifosfamide; Retrospective Studies; SARS-CoV-2	2022
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination. Infection, 2022, Volume: 50, Issue:5 Topics: Adrenal Cortex Hormones; Adult; COVID-19; COVID-19 Vaccines; Dexamethasone; Etoposide; Female; Ferritins; Humans; Immunoglobulins, Intravenous; Interleukin 1 Receptor Antagonist Protein; Lymphohistiocytosis, Hemophagocytic; Receptors, Interleukin-1; RNA, Messenger; SARS-CoV-2; Vaccination; Young Adult	2022
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. Blood advances, 2022, 11-22, Volume: 6, Issue:22 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine	2022
Gaucher Disease Type 2 Manifested as Hemophagocytic Lymphohistiocytosis in a Neonate in the COVID-19 Era. Journal of pediatric hematology/oncology, 2023, 05-01, Volume: 45, Issue:4 Topics: COVID-19; Etoposide; Gaucher Disease; Humans; Infant, Newborn; Lymphohistiocytosis, Hemophagocytic	2023
Haemophagocytic lymphohistiocytosis following a COVID-19 infection: case report. Journal of infection in developing countries, 2023, 03-31, Volume: 17, Issue:3 Topics: Adult; Bone Marrow; COVID-19; Cyclosporins; Etoposide; Fever; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged	2023
Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy. Human vaccines & immunotherapeutics, 2023, 12-31, Volume: 19, Issue:1 Topics: Aged; Antibodies, Viral; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Etoposide; Humans; Immunoglobulin G; Polyethylene Glycols; SARS-CoV-2; Thymus Neoplasms; Vaccination	2023
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2. British journal of haematology, 2020, Volume: 190, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Hydroxychloroquine; Idarubicin; Mediastinal Neoplasms; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; Prednisone; Procarbazine; SARS-CoV-2; Treatment Outcome; Vinblastine; Vincristine	2020
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19. International journal of hematology, 2020, Volume: 112, Issue:1 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Dose-Response Relationship, Drug; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophages; Pandemics; Pneumonia, Viral; SARS-CoV-2; Topoisomerase II Inhibitors	2020
Etoposide-based therapy for severe forms of COVID-19. Medical hypotheses, 2020, Volume: 142 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Humans; Influenza, Human; Lymphohistiocytosis, Hemophagocytic; Models, Theoretical; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2	2020
Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19. International journal of hematology, 2020, Volume: 112, Issue:1 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophages; Pandemics; Pneumonia, Viral; SARS-CoV-2; Topoisomerase II Inhibitors	2020
Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19. International journal of hematology, 2020, Volume: 112, Issue:1 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Etoposide; Humans; Inflammation; Lymphocyte Activation; Lymphohistiocytosis, Hemophagocytic; Pandemics; Pneumonia, Viral; SARS-CoV-2; T-Lymphocytes, Cytotoxic; Topoisomerase II Inhibitors	2020
Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients. The Journal of infection, 2020, Volume: 81, Issue:3 Topics: Adult; Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Etoposide; Female; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Topoisomerase II Inhibitors	2020
Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids. Frontiers in immunology, 2020, Volume: 11 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Etoposide; Humans; Immunomodulation; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Nitriles; Pandemics; Pneumonia, Viral; Pyrazoles; Pyrimidines; SARS-CoV-2	2020
Etoposide as Salvage Therapy for Cytokine Storm Due to Coronavirus Disease 2019. Chest, 2021, Volume: 159, Issue:1 Topics: Aged; COVID-19; Cytokine Release Syndrome; Etoposide; Female; Humans; Salvage Therapy; Severity of Illness Index	2021
The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients. Medical hypotheses, 2020, Volume: 144 Topics: Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Illness; Disease Outbreaks; Disease Progression; Drug Discovery; Drug Therapy, Combination; Etoposide; Humans; Irinotecan; SARS-CoV-2; Sepsis; Signal Transduction; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Treatment Outcome; Virus Internalization; Virus Replication	2020
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors. The oncologist, 2021, Volume: 26, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; COVID-19; Electronic Nicotine Delivery Systems; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; SARS-CoV-2; Testicular Neoplasms	2021
COVID-19 reinfection in two children with cancer. Pediatric hematology and oncology, 2021, Volume: 38, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Child, Preschool; Cisplatin; COVID-19; Cyclophosphamide; Daunorubicin; Etoposide; Humans; Male; Neuroblastoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reinfection; SARS-CoV-2; Vincristine	2021
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2. Pediatric hematology and oncology, 2021, Volume: 38, Issue:4 Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Child; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Etoposide; Female; Humans; Immunosuppressive Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lymphohistiocytosis, Hemophagocytic; SARS-CoV-2	2021
Etoposide for Cytokine Storm Because of Coronavirus Disease 2019. Chest, 2021, Volume: 159, Issue:4 Topics: COVID-19; Cytokine Release Syndrome; Cytokines; Etoposide; Humans; Salvage Therapy; SARS-CoV-2	2021